EN
HI
Ishita Drugs & Industries Chart
Ishita Drugs & Industries Share Key Metrics
Volume
1342.00
Market Cap
24.02 CR
LTQ@LTP
2@81.90
ATP
75.22
Var Margin
26.86 %
Circuit Range
64.28-96.4
Delivery %
- %
Value
1.01 L
ASM/GSM
No
Market Lot
1
Summary
Ishita Drugs & Industries share price is ₹81.9 as of 30 May, 2026. The stock Ishita Drugs & Industries intraday movement has stayed between ₹70.00 and ₹87.33, while on a 52-week basis,Ishita Drugs & Industries price 52 week high is ₹90.85 & its 52 week low is ₹66.00.
In terms of trading activity, Ishita Drugs & Industries has recorded a volume of 1342 shares, The Ishita Drugs & Industries has a market cap of ₹2990300 CR. The stock’s Average Traded Price (ATP) stands at ₹75.22, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 2 @ ₹81.90.
Ishita Drugs & Industries operates within a circuit range of ₹64.28 – ₹96.40, with a Value of ₹1.01 L. The Delivery Percentage for the day is -1%. Additionally, Ishita Drugs & Industries currently falls under the No framework, and trades with a market lot size of 1.
Ishita Drugs & Industries Fundamentals
View MoreP/E Ratio
0
P/B Ratio
0
Div. Yield
0
Sector P/E
55.51
Sector P/B
3.01
Sec. Div. Yield
0.55
Ishita Drugs & Industries Resistance and Support
Pivot 81.15
Resistance
First Resistance
86.3
Second Resistance
92.25
Third Resistance
97.4
Support
First Support
75.2
Second Support
70.05
Third Support
64.1
Ishita Drugs & Industries Corporate Actions
| Date | Agenda |
|---|---|
| 2026-05-30 | Audited Results |
| 2026-02-07 | Quarterly Results |
| 2025-11-11 | Quarterly Results |
| 2025-08-12 | Quarterly Results |
| 2025-06-13 | Others |
| 2025-05-30 | Audited Results |
| 2025-02-13 | Quarterly Results |
Ishita Drugs & Industries News
Ishita Drugs & Industries Ltd - 524400 - Board Meeting Intimation for Intimation Of Board Meeting Pursuant To Regulation 29 Of The SEBI (LODR) Regulations, 2015 For The Quarter And Year Ended 31St March, 2026
Ishita Drugs & Industries board is scheduled to meet on May 30, 2026. The key agenda items include the consideration and approval of the audited financial results for Q4 FY26 and the full fiscal year, along with the Directors' Report and re-appointment of internal auditors.
May 23 2026 18:02:43
Ishita Drugs & Industries Ltd - 524400 - Intimation Of Board Meeting Pursuant To Regulation 29 Of The SEBI (LODR) Regulations, 2015 For The Quarter And Year Ended 31St March, 2026
Ishita Drugs & Industries board will hold a meeting on May 30, 2026. The primary agenda includes considering and approving the audited financial results for Q4 FY26 and the full financial year. Additionally, the board will approve the Directors' Report and consider the re-appointment of internal auditors for 2026-27.
May 23 2026 15:17:35
Ishita Drugs & Industries Management
| Name | Position |
|---|---|
| Jagdish Agrawal | Managing Director |
| Abha Agrawal | Non Executive Director |
Ishita Drugs & Industries Similar Stocks
Gujarat Terce Laboratories Ltd.
35.25
0.49 (1.41%)
Gujarat Inject (Kerala) Ltd.
112.75
2.00 (1.81%)
Bacil Pharma Ltd.
49.05
-2.04 (3.99%)
Emmessar Biotech & Nutrition Ltd.
25.92
-0.01 (0.04%)
Cian Healthcare Ltd.
8.26
0.00 (0.00%)
Beryl Drugs Ltd.
20.84
0.99 (4.99%)
Sharma East India Hospitals & Medical Research Ltd
106.00
2.15 (2.07%)
Ishita Drugs & Industries FAQs
The Buying Price of Ishita Drugs & Industries share is 81.9 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Ishita Drugs & Industries stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Ishita Drugs & Industries, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Ishita Drugs & Industries shares is 0. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Ishita Drugs & Industries shares is 0. Useful to assess the stock's value relative to its book value.
To assess Ishita Drugs & Industries’s valuation compare Sector P/E, P/B which are 55.51 & 3.01 with sector averages, along with growth rates and financial metrics.
The Market Cap of Ishita Drugs & Industries is 24.02 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Ishita Drugs & Industries share price is 90.85 & 66.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Ishita Drugs & Industries belongs to the Healthcare sector.
